STK33 and neoplasm: Previous in vitro and in vivo studies have demonstrated that overexpression of STK33 promotes the malignant biological behaviors of pancreatic ductal adenocarcinoma (PDAC) cells, while its inhibition suppresses tumor cell malignancy [10].